D N Bateman|M D Rawlins - JoVE Visualize

Showing results (111-120 of 274) with videos related to

Pageof 28

Sort By:

British Journal of Clinical Pharmacology|November 18, 2003

The epidemiology of self-poisoning in the UKD R Camidge, R J Wood, D N Bateman

European Journal of Clinical Pharmacology|January 1, 1987

High-dose metoclopramide by infusion: a double-blind study of plasma concentration-effect relationships in patients receiving cancer chemotherapyW B Taylor, J M Simpson, D N Bateman

Clinical Toxicology (Philadelphia, Pa.)|May 16, 2007

Alerting and Surveillance Using Poisons Information Systems (ASPIS): outcomes from an international working groupW S Waring, S R Palmer, D N Bateman

Journal of Toxicology. Clinical Toxicology|January 1, 1985

Quinine amblyopia: is current management appropriate?E H Dyson, A T Proudfoot, D N Bateman

Emergency Medicine Journal : EMJ|September 24, 2009

The use of atropine in a nerve agent response with specific reference to children: are current guidelines too cautious?E A Sandilands, A M Good, D N Bateman

The British Journal of General Practice : the Journal of the Royal College of General Practitioners|January 1, 1997

Prescribing behaviour in general practice: the impact of promoting therapeutically equivalent cheaper medicinesS J Roberts, D N Bateman, J M Smith

Clinical Science (London, England : 1979)|December 1, 1980

The effect of age on the pharmacokinetics of diazepamA F Macklon, M Barton, O James, et al.

The British Journal of Dermatology|July 1, 1980

Decreased epidermal aryl hydrocarbon hydroxylase and localized pustular psoriasisS Shuster, M D Rawlins, P H Chapman, et al.

European Journal of Clinical Pharmacology|January 1, 1983

The pharmacokinetics of melphalan in patients with multiple myeloma: an intravenous/oral study using a conventional dose regimenK W Woodhouse, P Hamilton, A Lennard, et al.

European Journal of Clinical Pharmacology|June 15, 1976

Pharmacokinetics and pharmacodynamics of alprenolol in the treatment of hypertension. I. Relationship between plasma concentration and adrenergic beta-receptor blockadeP Collste, K Haglund, M Frisk-Holmberg, et al.

Pageof 28

Showing results (111-120 of 274) with videos related to

Sort By:

Pageof 28

British Journal of Clinical Pharmacology|November 18, 2003

The epidemiology of self-poisoning in the UKD R Camidge, R J Wood, D N Bateman

European Journal of Clinical Pharmacology|January 1, 1987

High-dose metoclopramide by infusion: a double-blind study of plasma concentration-effect relationships in patients receiving cancer chemotherapyW B Taylor, J M Simpson, D N Bateman

Clinical Toxicology (Philadelphia, Pa.)|May 16, 2007

Alerting and Surveillance Using Poisons Information Systems (ASPIS): outcomes from an international working groupW S Waring, S R Palmer, D N Bateman

Journal of Toxicology. Clinical Toxicology|January 1, 1985

Quinine amblyopia: is current management appropriate?E H Dyson, A T Proudfoot, D N Bateman

Emergency Medicine Journal : EMJ|September 24, 2009

The use of atropine in a nerve agent response with specific reference to children: are current guidelines too cautious?E A Sandilands, A M Good, D N Bateman

The British Journal of General Practice : the Journal of the Royal College of General Practitioners|January 1, 1997

Prescribing behaviour in general practice: the impact of promoting therapeutically equivalent cheaper medicinesS J Roberts, D N Bateman, J M Smith

Clinical Science (London, England : 1979)|December 1, 1980

The effect of age on the pharmacokinetics of diazepamA F Macklon, M Barton, O James, et al.

The British Journal of Dermatology|July 1, 1980

Decreased epidermal aryl hydrocarbon hydroxylase and localized pustular psoriasisS Shuster, M D Rawlins, P H Chapman, et al.

European Journal of Clinical Pharmacology|January 1, 1983

The pharmacokinetics of melphalan in patients with multiple myeloma: an intravenous/oral study using a conventional dose regimenK W Woodhouse, P Hamilton, A Lennard, et al.

European Journal of Clinical Pharmacology|June 15, 1976

Pharmacokinetics and pharmacodynamics of alprenolol in the treatment of hypertension. I. Relationship between plasma concentration and adrenergic beta-receptor blockadeP Collste, K Haglund, M Frisk-Holmberg, et al.

Pageof 28